Last reviewed · How we verify
tretamine
tretamine is a drug. It is currently in unknown development for Malignant tumor of ovary.
Triethylenemelamine is a small molecule used in chemotherapy. It is also known by other names, including NSC-9706, TRETAMINA, TRETAMINE, TRIETHYLENE MELAMINE, and TRIETHYLENEMELAMINE.
At a glance
| Generic name | tretamine |
|---|---|
| Therapeutic area | Oncology |
| Phase | unknown |
Approved indications
- Malignant tumor of ovary
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tretamine CI brief — competitive landscape report
- tretamine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about tretamine
What is tretamine?
tretamine is a pharmaceutical drug, indicated for Malignant tumor of ovary.
What is tretamine used for?
tretamine is indicated for Malignant tumor of ovary.
What development phase is tretamine in?
tretamine is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Malignant tumor of ovary
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing